Edges in Network
Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | NOL9 |
Upstream (Parents) |
---|
(<<) CBFA2T3 → NOL9 |
(<<) MYC → NOL9 |
(<<) NOC3L → NOL9 |
(<<) PDE2A → NOL9 |
(<<) PRKCZ → NOL9 |
(<<) RPS6KA1 → NOL9 |
(<<) RRP1 → NOL9 |
(<<) SYNPO → NOL9 |
(<<) TP53 → NOL9 |
(<<) TUBA1C → NOL9 |
Downstream (Children) |
---|
NOL9 → APH1B (>>) |
NOL9 → CASP10 (>>) |
NOL9 → CENPF (>>) |
NOL9 → CHODL (>>) |
NOL9 → CRTC1 (>>) |
NOL9 → ERBB2 (>>) |
NOL9 → GRB7 (>>) |
NOL9 → GRK5 (>>) |
NOL9 → GSK3A (>>) |